Advising a Biopharmaceutical Company on a Major Expansion of their Therapeutic Portfolio

Life Sciences

THE CLIENT

US Biopharma SME

Region

North America

Industry

Biopharmaceuticals

Division

Research & Development

THE CHALLENGE

Our Client, a multinational biopharmaceutical company, had a wide range of successful products. However, they recognized that gene therapeutics technology represented an important area of the biopharmaceutical market that they couldn’t effectively address. The Client wanted to quickly understand this unfamiliar competitive and technological terrain, and get actionable advice on the best direction for their own growth into this area. They contacted CamIn seeking guidance on their next steps.

10

experts assembled for the consulting team.

12

sub-areas covered within client's field of interest.

110

technologies identified and evaluated.

THE SOLUTION

CamIn worked with the Client’s research and development department to understand their goals for this expansion. We then assembled a team of more than ten leading experts on gene therapeutics, including several renowned university professors with expertise in in vivo gene therapeutics. We performed a thorough investigation of the technology area for the Client, delineating the relevant sub-areas (e.g. therapeutic agents, gene delivery tools) where they should consider focusing their R&D work.

 

We also evaluated each of these sub-areas, and the state-of-the-art technologies used in each area, considering the strengths, benefits, and market potential of each technology. In addition, CamIn shortlisted most promising disease areas and therapeutic approaches and forecast pre-clinical and early-stage clinical development pathways to recommend the most optimal technology assets for the expansion of the Client’s portfolio.

THE IMPACT

Our work, delivered in a comprehensive report and workshop with the Client’s R&D team, provided them with the information and the advice they needed to expand into this new area. CamIn’s team identified more than 110 technologies within the Client’s areas of interest, and provided a detailed evaluation which technologies best fit the Client’s strategies for commercialisation. The Client’s Head of R&D noted that the advice and results CamIn provided were “exactly what they wanted” and was surprised that they could be delivered in such an “exceptionally short amount of time”. Within six months of working with CamIn, the Client acquired one of the innovative biopharmaceutical companies that we had advised them about, and have effectively become a significant player in this sector of the biopharmaceutical market.

WOULD YOU LIKE TO LEARN MORE?

If you are looking to invest into emerging technologies, grow your innovation portfolio, and expand into new lucrative areas then we are ready to share our insights with you.

Dr Michal Wlodarski

Principal

Life Sciences

m.wlodarski [at] camin.com

+44 (0)7555 7953 50

Dr Dishant Mahendru

Managing Director

European Region

d.mahendru [at] camin.com

+44 (0)7388 6177 92

LIFE SCIENCES

GLOBAL Cosmetics MNC

Technology landscaping and forecasting of photo-protector specialty chemicals and formulations for sunscreen applications.

 

READ MORE

LIFE SCIENCES

EU FOOD MNC

Market-pull and technology-push analysis of food technologies for dysphagia and anorexia followed by in-depth product innovation strategy.

READ MORE

LIFE SCIENCES

EU MEDTECH SME

Conducted support on approval pathways for commercialisation, competitive advantage of clients technology, and scouting for partners for manufacturing.

 

READ MORE

See how our other Life Sciences clients benefited from engaging with CamIn.

visit

European Region

St John's Innovation Centre

Cowley Road

CB4 0WS Cambridge

United Kingdom

+44 (0)1223 926 926

North American Region

3532 Bee Caves Road

Suite 203

Austin TX 78746

United States of America

+1 (512) 988-2454

EMAIL

info [at] camin.com

follow

LinkedIn

Cambridge Innovation Consulting is an ISO certified organisation with 27001:2013 (# 317252019) and 9001:2015 (# 317242019) certifications.

COPYRIGHT 2019 - Cambridge Innovation Consulting